These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2866266)

  • 1. Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.
    Shirasawa Y; Fujii M; Nakamura M
    Jpn J Pharmacol; 1985 Sep; 39(1):77-82. PubMed ID: 2866266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of KRN2391, nitroglycerin and cromakalim in dihydroergotamine-treated pithed rats.
    Kaneta S; Kashiwabara T; Tanaka Y; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):963-8. PubMed ID: 7835645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of dihydroergotamine on the circulatory actions of arterial and venous dilators in the rat.
    de Metz JE; van Zwieten PA
    J Cardiovasc Pharmacol; 1981; 3(2):217-27. PubMed ID: 6166794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
    Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
    Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiohemodynamic effects of nipradilol (K-351) in the dog: comparison with propranolol, nadolol and prazosin.
    Kawada M; Satoh K; Taira N
    Jpn J Pharmacol; 1986 Sep; 42(1):9-18. PubMed ID: 2879055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
    Nakagawa Y; Nakahara H; Chin WP; Imai S
    Jpn J Pharmacol; 1985 Dec; 39(4):481-5. PubMed ID: 2419612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of dihydroergotamine at vascular 5-hydroxytryptamine receptors in pithed rats.
    Müller H; Glusa E; Markwardt F
    Pharmacology; 1988; 37(4):248-53. PubMed ID: 2904153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
    Noguchi K; Sakanashi M
    Br J Pharmacol; 1987 Jun; 91(2):411-9. PubMed ID: 2886171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production by R-alpha-methylhistamine of a histamine H3 receptor-mediated decrease in basal vascular resistance in guinea-pigs.
    McLeod RL; Gertner SB; Hey JA
    Br J Pharmacol; 1993 Oct; 110(2):553-8. PubMed ID: 7902173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of dihydroergotamine (DHE) on blood volume and circulation in the calf in peridural anesthesia in the human].
    Stühmeier KD; Stanton-Hicks M; Arndt JO
    Reg Anaesth; 1987 Oct; 10(4):109-13. PubMed ID: 3685475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
    Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of α
    Rivera-Mancilla E; Avilés-Rosas VH; Manrique-Maldonado G; Altamirano-Espinoza AH; Villanueva-Castillo B; MaassenVanDenBrink A; Villalón CM
    J Headache Pain; 2017 Oct; 18(1):104. PubMed ID: 29022279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nipradilol on venous hemodynamics: evaluation with a Doppler blood flow method.
    Maekawa K; Saito D; Kobayashi H; Mizuo K; Obayashi N; Uchida S; Haraoka S
    Acta Med Okayama; 1994 Apr; 48(2):87-91. PubMed ID: 8042538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological study of nicergoline. (III). Effects on cerebral and peripheral circulation in animals].
    Shintomi K; Ogawa Y; Yoshimoto K; Narita H
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):537-49. PubMed ID: 3732963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower body negative pressure: a method to differentiate vasodilators in the intact rat.
    de Metz JE; van Zwieten PA
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():341s-342s. PubMed ID: 120235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the prostanoid system in mediating the haemodynamic effects of dihydroergotamine.
    Bergqvist D; Lindblad B
    Ups J Med Sci; 1984; 89(3):227-32. PubMed ID: 6516064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
    Nakahara H; Nakazawa M; Takeda K; Imai S
    Jpn J Pharmacol; 1985 Dec; 39(4):487-92. PubMed ID: 2419613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α
    González-Hernández A; Lozano-Cuenca J; Marichal-Cancino BA; MaassenVanDenBrink A; Villalón CM
    J Headache Pain; 2018 May; 19(1):40. PubMed ID: 29802544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.